New Edition of the Technical Guide for the Elaboration of Ph. Eur. Monographs

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
The European Pharmacopoeia (Ph. Eur.) Commission published the 8th edition of the Technical Guide for the Elaboration of Monographs. The guide helps when drafting monographs and transferring analytical methods into a compendial procedure. The previous version of the guide dated back to 2015.
Highlights of the New Edition
The 8th edition contains, among others,
- The revision of the General Notices (1.),
- The implementation of the new General Chapter Balances (2.1.7),
- The harmonization of the General Chapter, Degree of coloration of liquids (2.2.2),
- The switch to a molecular sieve from phosphorous pentoxide in the revised General Chapter Loss on drying (2.2.32),
- A more detailed description for second identification tests,
- Information on when a reporting threshold should be included (depending on the analytical procedure used, i.e., external standardization or normalization) and whether one impurity or several (including the total) are to be quantified,
- An updated policy on genotoxic impurities following the ICH M7 guideline.
The revised technical guide also applies to the newly introduced Ph. Eur. medicinal product monographs.
Other available Ph. Eur. Technical Guides
Other helpful Technical Guides for the Elaboration of Ph. Eur. Monographs dedicated to special classes of substances and products, are the following ones on:
- Medicinal products containing chemically defined active substances
- Vaccines and immunosera for human use
- Synthetic peptides and recombinant DNA proteins
- Homoeopathic preparations
- Human plasma-derived products
- Radiopharmaceutical preparations
- Immunological veterinary medicinal products
- Vaccines for veterinary use
- Fatty oils and derivatives
- Herbal drugs and herbal drug preparations
More information is available in the EDQM Newsroom and under Ph. Eur. Technical Guides.
Related GMP News
10.02.2025USP Announces Corrections to General Chapter <1132.1> on Residual Host Cell Protein Measurement
10.02.2025FDA Warning Letter: Focus on Quality Control of APIs and Excipients
29.01.2025Revision of USP <1032> Design and Development of Biological Assays
23.01.2025English Translation of Supplement II to the Japanese Pharmacopoeia (JP18) Published
23.01.2025How to keep Analytical Systems Current and Compliant
23.01.2025FDA 483s due to Deficiencies in the Stability Program: Evaluation of Fiscal Year 2024